The blood pressure pill recall in the news covers one combination drug and one lot. It does not cover the three-drug pill that many people have been searching for.
According to the FDA's enforcement report, Ascend Laboratories is recalling amlodipine and olmesartan medoxomil tablets, 10 mg/40 mg, in 30-tablet bottles with lot number 25120696 and an expiration date of Dec. 31, 2026. The tablets were out of specification on dissolution, a lab test of how a tablet breaks down so the drug can be absorbed. The pills were made by Alkem Laboratories in India and distributed nationwide. The recall covers 11,424 bottles.
The FDA classified it as Class II, meaning use of the product may cause temporary or medically reversible health effects, with a remote chance of serious harm. Ascend started the recall on Oct. 6 and notified customers by letter.
The three-drug combination and a second recall
Searches for "olmesartan amlodipine hydrochlorothiazide recall" jumped Monday afternoon. That combination, which adds the diuretic hydrochlorothiazide and is sold under the brand Tribenzor and as generics, does not appear in any 2026 recall in the FDA's enforcement records. The last FDA record for it dates to 2014.
A second, separate recall involves a different pair of drugs. Viatris is pulling five lots of telmisartan and amlodipine tablets, 40 mg/5 mg, because the telmisartan content may exceed specifications, the enforcement report shows. That one is Class III, a level the FDA uses when a product is not likely to cause adverse health effects. The tablets were made for Mylan Pharmaceuticals, and the lot numbers are in the table below.
| Recall | Drug and strength | Lots | FDA class |
|---|---|---|---|
| Ascend Laboratories | Amlodipine and olmesartan, 10 mg/40 mg | 25120696 | II |
| Viatris (Mylan) | Telmisartan and amlodipine, 40 mg/5 mg | 3228113, 3228114, 3228115, 3228120, 3228121 | III |
What to do
Look at the label on your bottle for the drug name, strength and lot number. If they match, call your pharmacy about a replacement. Don't stop taking a prescribed blood pressure medicine without talking to your doctor or pharmacist first.
